rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12 Pt 2
|
pubmed:dateCreated |
1998-4-2
|
pubmed:abstractText |
In familial hyperaldosteronism type I (FH-I), glucocorticoid treatment suppresses adrenocorticotrophic hormone-regulated hybrid gene expression and corrects hyperaldosteronism.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0263-6352
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1729-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9488230-Adolescent,
pubmed-meshheading:9488230-Adult,
pubmed-meshheading:9488230-Aged,
pubmed-meshheading:9488230-Aldosterone,
pubmed-meshheading:9488230-Aldosterone Synthase,
pubmed-meshheading:9488230-Angiotensin II,
pubmed-meshheading:9488230-Blotting, Southern,
pubmed-meshheading:9488230-Dexamethasone,
pubmed-meshheading:9488230-Female,
pubmed-meshheading:9488230-Follow-Up Studies,
pubmed-meshheading:9488230-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:9488230-Glucocorticoids,
pubmed-meshheading:9488230-Humans,
pubmed-meshheading:9488230-Hyperaldosteronism,
pubmed-meshheading:9488230-Hypertension,
pubmed-meshheading:9488230-Infusions, Intravenous,
pubmed-meshheading:9488230-Male,
pubmed-meshheading:9488230-Middle Aged,
pubmed-meshheading:9488230-Polymerase Chain Reaction,
pubmed-meshheading:9488230-Potassium,
pubmed-meshheading:9488230-Prednisolone,
pubmed-meshheading:9488230-Renin,
pubmed-meshheading:9488230-Vasoconstrictor Agents
|
pubmed:year |
1997
|
pubmed:articleTitle |
Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I.
|
pubmed:affiliation |
University Department of Medicine, Greenslopes Hospital, Brisbane, Australia.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|